McDermott Will & Emery advised KeriMedical, a private company, which develops and manufactures a complete range of implants for hand and wrist surgery, on the acquisition by Medartis of the remaining 53% of its capital.

Following FDA approval of the KeriMedical TOUCH prosthesis on 10 July, the Medartis Group has decided to acquire the remaining 53% of the privately held company in accordance with the existing agreement.

The McDermott team comprised:

• Anne-France Moreau, partner, Fanny Rech, Lucie Martin, counsels, and Alice Villagrasa, associate

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.